Odelia Cooper is an Endocrinology/Metabolic physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 60 publications with 2,125 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8723 Alden Dr.
Ssb-290
Los Angeles, CA 900481804
Telephone
310-423-3870Registry record last updated 2 May 2012.
Clinical trials
- Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs
Sponsor: Cedars-Sinai Medical Center
- Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Sponsor: Cedars-Sinai Medical Center
- Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
Sponsor: Cedars-Sinai Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Rhythm Pharmaceuticals, Inc.Program year20251 payment
- Insulet CorporationProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
46.7%GLP-1 receptor agonist14.6%Ozempic76%Rybelsus24%Part D<11 patientsBiguanide (metformin)11.5%Metformin Hcl85%Metformin Hcl Er15%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
35.6%l-Thyroxine31.4%Levothyroxine Sodium62%Synthroid32%Tirosint6%Part D<11 patientsThyroid hormones2.1%Armour Thyroid100%Part D<11 patients+ 1 more class in this area
Cardiovascular
8.4%Statin4.6%Rosuvastatin Calcium63%Atorvastatin Calcium37%Part D<11 patientsCalcium channel blocker2.2%Amlodipine Besylate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2009–2016 per NIH RePORTER. The latest:
- ErbB receptor tyrosine kinase inhibitor therapy for aggressive prolactinomas
Cedars-Sinai Medical Center
FY2016$182,583R21DK105405 - ErbB receptor tyrosine kinase inhibitor therapy for aggressive prolactinomas
Cedars-Sinai Medical Center
FY2015$246,198R21DK105405
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors
The Journal of Clinical Endocrinology & Metabolism
2025 - Management of Recurrent and Aggressive Non-Functioning Pituitary Adenomas
Journal of Clinical Medicine
2025 - Growth Hormone Replacement in Craniopharyngioma: Analysis of the Hypopituitary Control and Complications Study (HypoCCS)
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Beth Karlan, MD
Cedars-Sinai Medical Center
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”